Attorney Zac Barnett is a Chicago-area fund finance lawyer and co-founder of Fund Finance Partners, where he advises fund sponsors on financing strategy, lender comparisons, and transaction structuring. Drawing on nearly two decades of experience in fund finance, private equity, and commercial lending, he has worked on complex facilities involving major investment banks, fund sponsors, and real estate investment participants. Zac Barnett has also contributed to industry discussion through articles, panel appearances, and the co-founding of the Fund Finance Association Annual Symposium. His background in subscription facilities, NAV lending, and regulatory issues provides a useful framework for examining how insurance companies are becoming more active participants in fund lending and how sponsors can adapt their planning, diligence, and documentation processes as lender profiles continue to widen.
Insurance Companies Expanding Into Fund Lending
Insurance companies are increasingly participating in fund lending, meaning credit facilities to private investment funds, as private funds expand and sponsors seek channels beyond traditional bank lenders. These facilities rely on investor commitments or the fund’s portfolio value. An insurer provides loan capital, and repayment depends on defined collateral. As insurers join banks, sponsors gain access to an additional source of structured financing.
Insurers generate capital by collecting premiums and setting aside reserves for future claims. Investment teams put those funds into assets that produce steady income and mature when payouts are due. To keep assets and liabilities aligned, they focus on cash-flow stability and term, and loans with clear repayment rights fit that discipline when maturities line up with expected claim payments.
Certain fund-finance products align with those preferences. A subscription credit line is a short-term loan, secured by investors’ capital commitments, so repayment can come from capital calls. A net asset value (NAV) loan relies on the value of the fund’s investments rather than uncalled commitments, and both structures identify a specific repayment source and collateral base that insurers can analyze as secured credit exposure.
Regulatory capital requirements influence allocation decisions. Insurance solvency rules require insurers to hold capital against assets based on their risk classification. Internal risk and investment teams evaluate how regulators and internal models classify the proposed fund loan for capital tests before approving an allocation. If a structure requires additional capital, the insurer must weigh the added capital cost against the expected return.
Once insurers clear internal tests, their participation can change how sponsors run the facility process. When insurers compete alongside banks on a subscription or NAV facility, sponsors may receive multiple term sheets and compare a bank proposal with a lower spread to an insurer proposal offering a longer term or more flexible covenants. More lender types widen structural options, but pricing still reflects credit quality and market conditions.
Bank and insurer approval pathways differ. A commercial bank routes a loan through its lending approval process, which evaluates borrower exposure limits and regulatory constraints, while an insurance company relies on an investment committee reviewing yield, term, and capital impact. Even when both committees review the same facility, they may emphasize different features, such as leverage levels or how quickly the lender can exit if performance deteriorates.
Because bank and insurer approval processes differ, sponsors adjust planning at the fund-formation stage. When sponsors align diligence timelines with insurer review cycles, they reduce delays. Advisors may model how lender types evaluate loan terms, borrowing-base design, draw mechanics, and reporting expectations. Early planning helps sponsors present a facility that satisfies underwriting standards for banks and fits insurers’ portfolio and capital objectives.
After the lender approves the structure, documentation governs execution. Loan agreements define collateral eligibility, concentration limits, reporting obligations, covenants, and contractual limits that the borrower must follow. The lender proposes protections, the sponsor negotiates thresholds, and counsel drafts enforceable provisions. Clear drafting and monitoring ensure that repayment rights and default remedies match the risk allocation agreed to at signing.
As insurers allocate capital within their regulatory and portfolio constraints, sponsors design facilities with multiple approval frameworks in mind. A structure that satisfies both bank lending approval processes and insurer investment committees can shorten execution timelines and reduce the risk of last-minute structural revisions. Rather than treating lender diversity as a pricing advantage alone, sponsors can treat it as a planning variable that shapes documentation sequencing, reporting cadence, and approval timing. That shift places process discipline, not just capital access, at the center of fund-level financing decisions.
About Zac Barnett
Zac Barnett is the co-founder of Fund Finance Partners and a Hinsdale, Illinois-based lawyer with extensive experience in fund finance, private equity, and commercial lending. He has represented clients in complex financing matters, spoken at industry events, and co-founded the Annual Global Subscription Credit Facility and Fund Finance Symposium. His work has been cited by publications including Bloomberg, Law360, and the Los Angeles Times.
